Priority Approval/Registration of Favipiravir Drugs During the COVID-19 Pandemic Ijaz Mustafa COVID-19 July 14, 2020January 18, 2022 Favipiravir_priority-approval_registration-of-drugs-during-the-covid-19-pandemicDownload Share this: Share on LinkedIn (Opens in new window) LinkedIn Share on WhatsApp (Opens in new window) WhatsApp Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X
